Статті в журналах з теми "Drug screening model"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Drug screening model".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
ANENE-NZELU, CHUKWUEMEKA, YAN WANG, HANRY YU, and LEO HWA LIANG. "LIVER TISSUE MODEL FOR DRUG TOXICITY SCREENING." Journal of Mechanics in Medicine and Biology 11, no. 02 (April 2011): 369–90. http://dx.doi.org/10.1142/s0219519411004083.
Повний текст джерелаGenri, Kawahara, and Yukiko Hayashi. "Drug screening using transgenic zebrafish model." Proceedings for Annual Meeting of The Japanese Pharmacological Society 94 (2021): 2—S17–3. http://dx.doi.org/10.1254/jpssuppl.94.0_2-s17-3.
Повний текст джерелаLiang, Qiying, Peng Ma, Qi Zhang, Youjie Yin, Ping Wang, Saifei Wang, Yao Zhang, Ruolei Han, and Hansong Deng. "A gum Arabic assisted sustainable drug delivery system for adult Drosophila." Biology Open 9, no. 6 (June 2, 2020): bio052241. http://dx.doi.org/10.1242/bio.052241.
Повний текст джерелаKondo, Jumpei, and Masahiro Inoue. "Application of Cancer Organoid Model for Drug Screening and Personalized Therapy." Cells 8, no. 5 (May 17, 2019): 470. http://dx.doi.org/10.3390/cells8050470.
Повний текст джерелаCagan, Ross. "Drug screening using model systems: some basics." Disease Models & Mechanisms 9, no. 11 (November 1, 2016): 1241–44. http://dx.doi.org/10.1242/dmm.028159.
Повний текст джерелаLiu, Chen, Tianyu Qin, Yuhan Huang, Yuan Li, Gang Chen, and Chaoyang Sun. "Drug screening model meets cancer organoid technology." Translational Oncology 13, no. 11 (November 2020): 100840. http://dx.doi.org/10.1016/j.tranon.2020.100840.
Повний текст джерелаParng, Chuenlei, Wen Lin Seng, Carlos Semino, and Patricia McGrath. "Zebrafish: A Preclinical Model for Drug Screening." ASSAY and Drug Development Technologies 1, no. 1 (November 2002): 41–48. http://dx.doi.org/10.1089/154065802761001293.
Повний текст джерелаCallahan, H. L., A. C. Portal, R. Devereaux, and M. Grogl. "An axenic amastigote system for drug screening." Antimicrobial Agents and Chemotherapy 41, no. 4 (April 1997): 818–22. http://dx.doi.org/10.1128/aac.41.4.818.
Повний текст джерелаDixit, Vaibhav A. "A simple model to solve a complex drug toxicity problem." Toxicology Research 8, no. 2 (2019): 157–71. http://dx.doi.org/10.1039/c8tx00261d.
Повний текст джерелаDecker, S., M. Hollingshead, C. A. Bonomi, J. P. Carter, and E. A. Sausville. "The hollow fibre model in cancer drug screening." European Journal of Cancer 40, no. 6 (April 2004): 821–26. http://dx.doi.org/10.1016/j.ejca.2003.11.029.
Повний текст джерелаAhmed, Shamima Nasreen, Biswajit Das, and Jashabir Chakraborty. "PROSPECTIVE AND RETROSPECTIVE ANIMAL MODEL USED IN THE PHARMACOLOGICAL SCREENING OF ANTI-CANCER DRUG." International Journal of Current Pharmaceutical Research 10, no. 4 (July 16, 2018): 13. http://dx.doi.org/10.22159/ijcpr.2018v10i4.28472.
Повний текст джерелаPuscas, Ina, Florian Bernard-Patrzynski, Martin Jutras, Marc-André Lécuyer, Lyne Bourbonnière, Alexandre Prat, Grégoire Leclair, and V. Gaëlle Roullin. "IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening." Pharmaceutics 11, no. 11 (November 8, 2019): 587. http://dx.doi.org/10.3390/pharmaceutics11110587.
Повний текст джерелаCheng, Lijun, Abhishek Majumdar, Daniel Stover, Shaofeng Wu, Yaoqin Lu, and Lang Li. "Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine." Genes 11, no. 3 (February 28, 2020): 263. http://dx.doi.org/10.3390/genes11030263.
Повний текст джерелаLiao, Shuyi, Wenmin Yang, Ting Yu, Lu Dai, Xiaoliang Liu, Jiangping Zhang, Jinghong Zhao, and Chi Liu. "Establishment of a Drug Screening Model for Cardiac Complications of Acute Renal Failure." Biomolecules 11, no. 9 (September 16, 2021): 1370. http://dx.doi.org/10.3390/biom11091370.
Повний текст джерелаNoguchi, Yoshihiro, Tomoya Tachi, and Hitomi Teramachi. "Subset Analysis for Screening Drug–Drug Interaction Signal Using Pharmacovigilance Database." Pharmaceutics 12, no. 8 (August 12, 2020): 762. http://dx.doi.org/10.3390/pharmaceutics12080762.
Повний текст джерелаMoya, Elisa L. J., Elodie Vandenhaute, Eleonora Rizzi, Marie-Christine Boucau, Johan Hachani, Nathalie Maubon, Fabien Gosselet, and Marie-Pierre Dehouck. "Miniaturization and Automation of a Human In Vitro Blood–Brain Barrier Model for the High-Throughput Screening of Compounds in the Early Stage of Drug Discovery." Pharmaceutics 13, no. 6 (June 16, 2021): 892. http://dx.doi.org/10.3390/pharmaceutics13060892.
Повний текст джерелаVeit, Joachim G. S., Bhaskar Birru, Ruby Singh, Elizabeth M. Arrigali, and Monica A. Serban. "An In Vitro Model for Characterization of Drug Permeability across the Tympanic Membrane." Pharmaceuticals 15, no. 9 (September 7, 2022): 1114. http://dx.doi.org/10.3390/ph15091114.
Повний текст джерелаKato, Yuki, Yutaka Tonomura, Hiroyuki Hanafusa, Kyohei Nishimura, Tamio Fukushima, and Motonobu Ueno. "Adult Zebrafish Model for Screening Drug-Induced Kidney Injury." Toxicological Sciences 174, no. 2 (February 10, 2020): 241–53. http://dx.doi.org/10.1093/toxsci/kfaa009.
Повний текст джерелаHamilton, Lloyd, Dirk Sieger, Belen Rubio Ruiz, and Asier Unciti-broceta. "A novel zebrafish xenograft model for immunotherapeutic drug screening." Neuro-Oncology 20, suppl_1 (January 2018): i14. http://dx.doi.org/10.1093/neuonc/nox238.063.
Повний текст джерелаStilwell, Geoff E., Sudipta Saraswati, J. Troy Littleton, and Scott W. Chouinard. "Development of aDrosophilaseizure model forin vivohigh-throughput drug screening." European Journal of Neuroscience 24, no. 8 (October 2006): 2211–22. http://dx.doi.org/10.1111/j.1460-9568.2006.05075.x.
Повний текст джерелаKaarj, Kattika, Jennifer Ngo, Christina Loera, Patarajarin Akarapipad, Soohee Cho, and Jeong-Yeol Yoon. "Simple Paper-based Liver Cell Model for Drug Screening." BioChip Journal 14, no. 2 (June 2020): 218–29. http://dx.doi.org/10.1007/s13206-020-4211-6.
Повний текст джерелаOvics, Paz, Danielle Regev, Polina Baskin, Mor Davidor, Yuval Shemer, Shunit Neeman, Yael Ben-Haim, and Ofer Binah. "Drug Development and the Use of Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Disease Modeling and Drug Toxicity Screening." International Journal of Molecular Sciences 21, no. 19 (October 3, 2020): 7320. http://dx.doi.org/10.3390/ijms21197320.
Повний текст джерелаNakarin, Fahsai, Kajjana Boonpalit, Jiramet Kinchagawat, Patcharapol Wachiraphan, Thanyada Rungrotmongkol, and Sarana Nutanong. "Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation." Molecules 27, no. 4 (February 11, 2022): 1226. http://dx.doi.org/10.3390/molecules27041226.
Повний текст джерелаLee, Sung Hak, Jung Won Kang, Tao Lin, Jae Eun Lee, and Dong Il Jin. "Teratogenic Potential of Antiepileptic Drugs in the Zebrafish Model." BioMed Research International 2013 (2013): 1–6. http://dx.doi.org/10.1155/2013/726478.
Повний текст джерелаXie, Yujiang, Genpei Shi, Jie Sun, Si Li, Wei Gao, Yimin Hu, Chang Zu, Weiwei Tang, and Junbo Gong. "Computational Screening and Experimental Validation on Multicomponent Crystals of a New Class of Janus Kinase (JAK) Inhibitor Drug with Improved Solubility." Crystals 12, no. 12 (November 27, 2022): 1722. http://dx.doi.org/10.3390/cryst12121722.
Повний текст джерелаWang, Jianzheng, Jinxi Huang, Hui Wang, Wei Yang, Qiwen Bai, Zhentao Yao, Qingli Li, et al. "Personalized Treatment of Advanced Gastric Cancer Guided by the MiniPDX Model." Journal of Oncology 2022 (January 27, 2022): 1–11. http://dx.doi.org/10.1155/2022/1987705.
Повний текст джерелаSingh, Ruby, Bhaskar Birru, Joachim G. S. Veit, Elizabeth M. Arrigali, and Monica A. Serban. "Development and Characterization of an In Vitro Round Window Membrane Model for Drug Permeability Evaluations." Pharmaceuticals 15, no. 9 (September 5, 2022): 1105. http://dx.doi.org/10.3390/ph15091105.
Повний текст джерелаWang, Zhaohui, Emilio Cortes-Sanchez, Chieh-Hsiang Yang, Daniel Nelson, Daniel Delubac, Shiaowen David Hsu, Alana Welm, and Xiling Shen. "Micro-organospheres: An automated patient-derived model platform for rapid drug screening of breast cancer." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): e12628-e12628. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e12628.
Повний текст джерелаSofela, Samuel, Sarah Sahloul, and Yong-Ak Song. "Biophysical analysis of drug efficacy on C. elegans models for neurodegenerative and neuromuscular diseases." PLOS ONE 16, no. 6 (June 11, 2021): e0246496. http://dx.doi.org/10.1371/journal.pone.0246496.
Повний текст джерелаOrdas, Anita, Robert-Jan Raterink, Fraser Cunningham, Hans J. Jansen, Malgorzata I. Wiweger, Susanne Jong-Raadsen, Sabine Bos, et al. "Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen." Antimicrobial Agents and Chemotherapy 59, no. 2 (November 10, 2014): 753–62. http://dx.doi.org/10.1128/aac.03588-14.
Повний текст джерелаJungwirth, Gerhard, Tao Yu, Cao Junguo, Catharina Lotsch, Andreas Unterberg, and Christel Herold-Mende. "TMOD-29. STANDARDIZED GENERATION OF TUMOR-ORGANOIDS AS NOVEL DRUG SCREENING MODEL IN MENINGIOMA." Neuro-Oncology 23, Supplement_6 (November 2, 2021): vi221—vi222. http://dx.doi.org/10.1093/neuonc/noab196.890.
Повний текст джерелаNii, Teruki. "Strategies Using Gelatin Microparticles for Regenerative Therapy and Drug Screening Applications." Molecules 26, no. 22 (November 10, 2021): 6795. http://dx.doi.org/10.3390/molecules26226795.
Повний текст джерелаMontanari, Floriane, Anna Cseke, Katrin Wlcek, and Gerhard F. Ecker. "Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors." SLAS DISCOVERY: Advancing the Science of Drug Discovery 22, no. 1 (July 11, 2016): 86–93. http://dx.doi.org/10.1177/1087057116657513.
Повний текст джерелаDeng, Lei, Yibiao Huang, Xuejun Liu, and Hui Liu. "Graph2MDA: a multi-modal variational graph embedding model for predicting microbe–drug associations." Bioinformatics 38, no. 4 (November 23, 2021): 1118–25. http://dx.doi.org/10.1093/bioinformatics/btab792.
Повний текст джерелаDoh, Il, Yong-Jun Kwon, Bosung Ku, and Dong Woo Lee. "Drug Efficacy Comparison of 3D Forming and Preforming Sphere Models with a Micropillar and Microwell Chip Platform." SLAS DISCOVERY: Advancing the Science of Drug Discovery 24, no. 4 (February 12, 2019): 476–83. http://dx.doi.org/10.1177/2472555218821292.
Повний текст джерелаStackhouse, Christian T., James R. Rowland, Rachael S. Shevin, Raj Singh, G. Yancey Gillespie, and Christopher D. Willey. "A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening." Cells 8, no. 7 (July 11, 2019): 702. http://dx.doi.org/10.3390/cells8070702.
Повний текст джерелаChoi, Tae-Woo, Jeong Cho, Joohong Ahnn, and Hyun-Ok Song. "Novel Findings of Anti-Filarial Drug Target and Structure-Based Virtual Screening for Drug Discovery." International Journal of Molecular Sciences 19, no. 11 (November 13, 2018): 3579. http://dx.doi.org/10.3390/ijms19113579.
Повний текст джерелаDi Veroli, Giovanni Y., Mark R. Davies, Henggui Zhang, Najah Abi-Gerges, and Mark R. Boyett. "High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment." American Journal of Physiology-Heart and Circulatory Physiology 304, no. 1 (January 1, 2013): H104—H117. http://dx.doi.org/10.1152/ajpheart.00511.2012.
Повний текст джерелаMaeng, Ju Eun, Ha-Young Seo, Soon-Chan Kim, and Ja-Lok Ku. "Novel Drug Screening Platform: Tumor Organoid." Korean Journal of Pancreas and Biliary Tract 26, no. 4 (October 31, 2021): 233–40. http://dx.doi.org/10.15279/kpba.2021.26.4.233.
Повний текст джерелаNie, Xialin, Zhixing Liang, Kun Li, Haoyuan Yu, Yuhan Huang, Linsen Ye, and Yang Yang. "Novel organoid model in drug screening: Past, present, and future." Liver Research 5, no. 2 (June 2021): 72–78. http://dx.doi.org/10.1016/j.livres.2021.05.003.
Повний текст джерелаWang, Yan-Ying, Wei-Wei Ma, and I.-Feng Peng. "Screening of sleep assisting drug candidates with a Drosophila model." PLOS ONE 15, no. 7 (July 29, 2020): e0236318. http://dx.doi.org/10.1371/journal.pone.0236318.
Повний текст джерелаKawahara, G., J. A. Karpf, J. A. Myers, M. S. Alexander, J. R. Guyon, and L. M. Kunkel. "Drug screening in a zebrafish model of Duchenne muscular dystrophy." Proceedings of the National Academy of Sciences 108, no. 13 (March 14, 2011): 5331–36. http://dx.doi.org/10.1073/pnas.1102116108.
Повний текст джерелаTims, F. M., A. M. Horton, and B. F. Fletcher. "Screening for Cognitive impairment with drug addicts: The DATOS model." Archives of Clinical Neuropsychology 7, no. 4 (January 1, 1992): 367. http://dx.doi.org/10.1093/arclin/7.4.367.
Повний текст джерелаSharma, Pallavi, Supriya Sharma, Vikram Patial, Damanpreet Singh, and Yogendra Shantaram Padwad. "Zebrafish (Danio rerio): A potential model for nephroprotective drug screening." Clinical Queries: Nephrology 3, no. 2-4 (April 2014): 97–105. http://dx.doi.org/10.1016/j.cqn.2014.11.002.
Повний текст джерелаJamieson, Laura, Donna Meckoll-Brinck, and Nancy Keller. "Characterized and predictable rabbit uveitis model for antiinflammatory drug screening." Journal of Pharmacological Methods 21, no. 4 (July 1989): 329–38. http://dx.doi.org/10.1016/0160-5402(89)90070-3.
Повний текст джерелаLee, Myoung Woo, Hye Jin Kim, Dae Seong Kim, Meong Hi Son, Soo Hyun Lee, Hye Lim Jung, Keon Hee Yoo, Ki Woong Sung, and Hong Hoe Koo. "Establishment of Bioluminescence Imaging Based Leukemia In Vivo Model for Preclinical Testing." Blood 118, no. 21 (November 18, 2011): 4879. http://dx.doi.org/10.1182/blood.v118.21.4879.4879.
Повний текст джерелаGaikwad, Pooja Popat, Vishal S. Adak, and Rajkumar V. Shete. "The Screening models for antiepileptic drugs: A Review." Journal of Drug Delivery and Therapeutics 11, no. 2-S (April 15, 2021): 175–78. http://dx.doi.org/10.22270/jddt.v11i2-s.4809.
Повний текст джерелаAntonia, Ricardo J., Kan Toriguchi, Eveliina Karelehto, Dania Annuar, Luika Timmerman, Noura Tbeileh, Aras N. Mattis, et al. "Patient-derived organoids for personalized drug screening in intrahepatic cholangiocarcinoma." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 581. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.581.
Повний текст джерелаRen, Ji-Xia, Rui-Tao Zhang, and Hui Zhang. "Identifying Novel ATX Inhibitors via Combinatory Virtual Screening Using Crystallography-Derived Pharmacophore Modelling, Docking Study, and QSAR Analysis." Molecules 25, no. 5 (March 2, 2020): 1107. http://dx.doi.org/10.3390/molecules25051107.
Повний текст джерелаNainu, Firzan, Muh Akbar Bahar, Sartini Sartini, Reski Amalia Rosa, Nur Rahmah, Reski Amelia Kamri, Nur Rahma Rumata, Risfah Yulianty, and Elly Wahyudin. "Proof-of-Concept Preclinical Use of Drosophila melanogaster in the Initial Screening of Immunomodulators." Scientia Pharmaceutica 90, no. 1 (February 8, 2022): 11. http://dx.doi.org/10.3390/scipharm90010011.
Повний текст джерела